Ozempic maker’s CEO blames insurance companies for weight-loss drug prices

The chief executive of the company behind Ozempic and Wegovy blamed insurers and middlemen for the high costs of weight-loss drugs in the U.S. during a congressional testimony on Tuesday. Why it matters: Lars Fruergaard Jørgensen, who leads drug manufacturer Novo Nordisk, passed along accountability for access to these medications while being questioned about his company’s role in setting prices.”We don’t decide the price for patients…
Read More